Le Huynh Hoai Thuong

Mr. Le Huynh Hoai Thuong

China Medical University, Taichung, Taiwan
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
CTChih-hung Tsai
Chih-hung Tsai
YLYuan Ho Lin
Yuan Ho Lin
YLYung-Sheng Li
Yung-Sheng Li
Trung-Loc HoTrung-Loc Ho
Trung-Loc Ho
LTLe Huynh Hoai Thuong
Le Huynh Hoai Thuong
YLYu-Huei Liu
Yu-Huei Liu
Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of typical chemotherapeutics among cancer survivors. Despite the recent progress, the effective prevention and treatment strategies for CIPN remain limited. Better understanding of the pathogenesis of CIPN may provide new niches for developing a new ideal therapeutic strategy. This review summarizes the current understanding of CIPN and current recommendations along with completed/active clinical trials and aims to foster translational research to improve the development of effective strategies for managing CIPN.

Verified
Journal Article
Open access
PDF file
LTLe Huynh Hoai Thuong
Le Huynh Hoai Thuong
CHChang-Lun Huang
Chang-Lun Huang
CLChun-Lin Liu
Chun-Lin Liu
JGJeng-Hung Guo
Jeng-Hung Guo
PLPo-I Liu
Po-I Liu
CTChih-Hsin Tang
Chih-Hsin Tang
Lung cancer carries a high mortality burden, with metastatic dissemination accounting for much of its poor prognosis. Bone sialoprotein (BSP), a matricellular protein belonging to the SIBLING family, has been associated with tumor invasion; nonetheless, its role in lung cancer remains inadequately characterized. Clinical database analysis indicates that BSP is the most critical SIBLING protein associated with lung cancer proliferation and metastasis. Our clinical data also confirmed that BSP levels are higher in metastatic lung cancer compared to non-metastatic cases. We further demonstrate that BSP promotes lung cancer progression and motility through upregulated ADAM9 expression. Mechanistically, we revealed that BSP enhances ADAM9-dependent proliferation and motility via the FAK pathway. In addition, the hsa_circ_0084050/miR-373-3p regulatory axis contributes to BSP-mediated ADAM9 regulation. In an exploratory mouse metastasis model established by caudal artery injection of A549 control or stable BSP-shRNA cells into male BALB/c nude mice, BSP knockdown was associated with a lower metastatic tumor burden. Therefore, BSP may serve as a therapeutic target for limiting lung cancer progression and metastatic dissemination.